Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
11/2007
11/07/2007EP0979071B1 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
11/01/2007WO2007122956A1 Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle
11/01/2007WO2007072147A3 Composition for diagnosing and treating circulatory system diseases
11/01/2007WO2007015105A3 Nanoparticles comprising antibacterial ligands
11/01/2007US20070254349 Preparation for the Photodynamic Control of Micro-Organisms and Use Thereof
10/2007
10/31/2007EP1848504A2 Wound treatment device for photodynamic therapy and method of using same
10/31/2007EP1755584A4 Treatment of myopia
10/30/2007US7288225 Psyllium plant extracts; constipation therapy, gastrointestinal disorders
10/30/2007US7287646 Diagnosis and treatment of cervical and bladder cancer; improved photochemotherapeutic properties; antineoplastic agents
10/30/2007CA2377293C Real-time monitoring of photodynamic therapy over an extended time
10/25/2007WO2007118303A2 Method for the treatment of skin tissues
10/25/2007WO2007118294A1 Homeopathic composition and kit therefore
10/25/2007US20070249822 Photolabile Coumarinylmethyl Esters of Cyclic Nucleotides, Methods for their Preparation and Their Use
10/25/2007US20070248534 Auger effect-based cancer therapy method
10/25/2007CA2643807A1 Homeopathic composition and kit therefore
10/24/2007EP1847830A1 Determining optimal concentrations of protective additives for biomolecules
10/24/2007EP1847267A2 Method of photodynamic diagnosis for vascular diseases
10/18/2007WO2007116808A1 Virus particle-like structure and pharmaceutical preparation comprising the same
10/18/2007US20070243138 Hollow microspheres with controlled fragility for medical use
10/18/2007CA2648691A1 Optical coherence tomographic detection of cells and killing of the same
10/17/2007EP1844794A1 Silicon implants comprising a radionucleotide and/or a cytotoxic drug and their use in cancer treatment
10/17/2007EP1073473B1 Improvements in or relating to contrast agents
10/17/2007EP1059882B1 Integrated tissue poration, fluid harvesting and analysis device
10/16/2007US7282241 Patterned, high surface area substrate with hydrophilic/hydrophobic contrast, and method of use
10/16/2007US7282215 Supports for photosensitizer formulations
10/16/2007CA2248087C Improved vision through photodynamic therapy of the eye
10/11/2007WO2007010442A3 Method and system for in vivo drug delivery
10/11/2007US20070237787 Methods for use of tslp and agonists and antagonists thereof
10/11/2007US20070237711 Method of Increasing Radiation Sensitivity by Inhibition of Beta One Integrin
10/10/2007EP1842561A1 Method and device for UV-inactivation of virus in blood products
10/10/2007EP1842560A1 A high-intensity focused ultrasound adjuvant and the screening method thereof
10/10/2007EP1842559A1 Particle adjuvant for hifu therapy and the use thereof
10/10/2007EP1842554A1 Coated magnetic particle containing preparation, process for producing the same and diagnostic therapeutic system
10/10/2007EP1841468A2 Laser activated nanothermolysis of cells
10/09/2007US7279575 Such as 2-(2-aminopyrimidin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one hydrochloride; for treatment of cell proliferative disorders/cancer; kits
10/09/2007US7279160 Combinations of DR5 antibodies and other therapeutic agents
10/04/2007WO2007085238A3 Multifunctional mixture of active substances
10/04/2007US20070231559 Patterned, high surface area substrate with hydrophilic/hydrophobic contrast, and method of use
10/04/2007US20070231393 System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
10/04/2007US20070231352 Mucoadhesive thermoresponsive medicament-carrier composition
10/04/2007US20070231255 Method for the Treatment of Mammalian Skin Tissues Via Pulse Irradiation in the Presence of a Photoactive Compound
10/03/2007EP1840213A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein
10/03/2007EP1839677A1 Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof
10/03/2007EP1838354A2 Radioactive device
10/03/2007CN100340302C Device and process for treating a liquid medium using ultrasound in preventing the growth of hyperproliferative or infected cells
10/02/2007US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides
10/02/2007US7276494 Photodynamic therapy; anticancer agents, vision defects, autoimmune disease, restenosis, skin disorders; cancer vaccine; medical diagnosis
10/02/2007US7276344 Osteoclastogenesis inhibitory factor protein for treating osteoporosis
10/02/2007US7276254 Emulsion/aggregation polymeric microspheres for biomedical applications and methods of making same
09/2007
09/27/2007WO2007107764A1 Reversibly inhibited antibodies for immune cell stimulation
09/27/2007WO2007107762A1 Indirect heating
09/27/2007US20070224264 Remote Control Release of Encapsulated Material
09/26/2007EP1837032A2 Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions
09/26/2007CN101043905A Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor
09/25/2007US7273458 Method of applying acoustic energy effective to alter transport or cell viability
09/25/2007CA2204160C Treatment of urogenital cancer with boron neutron capture therapy
09/20/2007WO2007106501A2 Combined energy and topical composition application for regulating the condition of mammalian skin
09/20/2007US20070217996 Activatable Particles, Preparations and Uses
09/20/2007CA2644502A1 Combined energy and topical composition application for regulating the condition of mammalian skin
09/18/2007US7271261 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2)
09/13/2007WO2007103132A2 Method and apparatus for acne treatment using low intensity light therapy
09/13/2007WO2007102375A1 METHOD FOR PRODUCING MgFe2O4 TO BE USED AS LIVING ORGANISM HEATING MATERIAL AND MgFe2O4 OBTAINED BY SUCH PRODUCTION METHOD
09/13/2007WO2007101641A1 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity
09/13/2007WO2006138330A3 Tissue treatment methods
09/13/2007US20070212406 Homeopathic drug composition and methods of use thereof
09/13/2007DE102005061738A1 SI-card holder for the individual therapy information of the patient, comprises a suitable cut-out section at the back side of the SI-card holder, and a re-lockable flap at the front side of the SI-card holder
09/13/2007CA2645168A1 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity
09/13/2007CA2644219A1 Method and apparatus for acne treatment using low intensity light therapy
09/12/2007EP1830882A2 Process for the preparation of a boron-substituted porphyrin
09/12/2007EP1830879A2 Mri guided photodynamic therapy for cancer
09/12/2007EP1368038B1 Medicament for the administration of amifostine and related compounds
09/12/2007CN101035835A Biodegradable cationic polymers
09/11/2007US7268155 Photosensitizer conjugates for pathogen targeting
09/11/2007US7267778 Has ultrasound emitter located relative to compartment of container holding liquid medium and microbubble emitter relative to compartment; produces water supersaturated with salts to induce biotoxic effects on microorganisms
09/05/2007CN101031320A Therapy device and related accessories, compositions, and treatment methods
09/05/2007CN101031319A Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs
09/05/2007CN100335132C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
09/04/2007US7265100 Separation of regioisomers of metal phthalocyanines
09/04/2007US7264629 Photodynamic therapy for the treatment of hair loss
09/04/2007CA2134479C Laser treatment
08/2007
08/30/2007WO2007097473A1 Organic magnetic nanocomplex having functional molecule introduced therein
08/30/2007WO2006119211A3 Methods and compositions for treating ocular disorders
08/30/2007US20070203027 5-Aminolevulinic Acid Salt, Process For Producing The Same And Use Thereof
08/29/2007EP1604673B1 Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method
08/29/2007CN101027059A Combination comprising ZD6474 and imatinib
08/28/2007US7262173 Chemosensitizing with liposomes containing oligonucleotides
08/23/2007WO2006102471A3 Apparatus and method for pre-conditioning/fixation and treatment of diseases with heat activation/release with thermoactivated drugs and gene products
08/23/2007US20070197953 Magnetic particles for therapeutic treatment
08/23/2007US20070196281 Method and articles for remote magnetically induced treatment of cancer and other diseases, and method for operating such article
08/22/2007EP1820514A2 Therapeutic compositions that produce an immune response by altering the antigen
08/22/2007EP1819360A1 Method of treating microorganisms in the oral cavity via photodynamic therapy employing a non-coherent light source
08/22/2007CN1332658C Antibacterial compositions comprising metal phthalocyanine analogues
08/22/2007CN101020061A Prepn process of ultrasonically controlled releasing micro gel containing medicine
08/21/2007US7259001 Culturing a plurality of yeast cells of Saccharomyces cerevisiae Hansen AS2.502 in the presence of an alternating electric field having a frequency in the range of about 7900 to 13200 MHz and a field strength in the range of about 240 to 500 mV/cm for 60 168 hours
08/21/2007CA2257579C Genistein as a preventive against ultraviolet induced skin photodamage and cancer
08/16/2007US20070191822 Method and apparatus for acne prevention
08/16/2007US20070191329 Ethylene glycol esters as photoactive agents
08/16/2007US20070189968 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue
08/16/2007US20070189963 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
08/15/2007EP1818333A1 Vanilloid receptor ligands and their use in treatments
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 95